Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Hoeper (Hannover, Germany). Pulmonary arterial hypertension-related morbidity is prognostic for survival: insights from the SERAPHIN and GRIPHON studies. 1981

Member's Comments

No comment yet.

Related content which might interest you: Validation of a prognostic score for pulmonary embolism short-term mortality Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019 Year: 2020 Survival in pulmonary hypertension in Spain: insights from the Spanish registry}, Source: Eur Respir J 2012; 40: 596-603 Year: 2012 Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN Source: Eur Respir J 2015; 46: 1711-1720 Year: 2015 Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the French registry Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Using controlled and real-world data in concert to assess survival benefits in pulmonary arterial hypertension: Insights from SERAPHIN and REVEAL Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials Year: 2017 Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 342s Year: 2007 New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension Source: Eur Respir Rev 2013; 22: 495-502 Year: 2013 Interpreting risk reduction in clinical trials for pulmonary arterial hypertension Source: Eur Respir Rev, 27 (148) 180020; 10.1183/16000617.0020-2018 Year: 2018 Biochemical predictors of mortality in pulmonary embolism Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 The study of risk in pulmonary arterial hypertension Source: Eur Respir Rev 2012 21:234-238 Year: 2012 Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Towards prognostic biomarkers in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 799-801 Year: 2012 Clinical in-hospital mortality profile of pulmonary embolism Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 A critical analysis of survival in pulmonary arterial hypertension Source: Eur Respir Rev 2012 21:218-222 Year: 2012 Non-invasive mortality predictors in pediatric pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 Impact of functional class change on survival in patients with pulmonary arterial hypertension in the REVEAL registry Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry Source: ERJ Open Res, 7 (2) 00046-2021; 10.1183/23120541.00046-2021 Year: 2021 Improving survival in pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 218-220 Year: 2005